Funded by Health Canada, initiative to expand provincewide to curb ongoing opioid crisis and retain more individuals in opioid agonist therapy
China CDC and the BC Centre for Excellence in HIV/AIDS strengthen their partnership in support of Treatment as Prevention¨ to curb the impact of HIV/AIDS
New findings bring Canada’s largest HIV research, treatment & education organization, the BC Centre for Excellence in HIV/AIDS (BC-CfE), into the area of HIV vaccine and cure research
The BC Centre for Excellence in HIV/AIDS (BC-CfE) announced Dr. Zabrina Brumme has been appointed Director of Canada’s leading HIV laboratory program.
The BC-CfE announces a new training program to support BC nurse practitioners to prescribe antiretrovirals (ARVs) for HIV prevention and treatment, as part of the Treatment as Prevention¨ strategy
In the absence of treatment, genetic mutations of HIV can lead to more rapid progression to AIDS, highlighting the urgent need for testing and treatment
People throughout B.C. are benefiting from expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), as strong uptake for the publicly funded drug continues to grow.
Women living with HIV who experience higher levels of racism are less likely to be engaged in HIV care, according to research from the BC Centre for Excellence in HIV/AIDS (BC-CfE), BC Women’s Hospital and Simon Fraser University (SFU) published today in the Journal of Acquired Immune Deficiency Syndromes (JAIDS). This finding is based on analysis of a cohort of over 1,400 women living with HIV in British Columbia, Ontario and Quebec enrolled in CHIWOS, Canada’s largest ongoing community-based study.
Reaching people living with HIV with care, treatment and support to improve their longevity and quality of life, and to prevent new infections (a concept known as Treatment as Prevention¨, or TasP¨) has helped bring the HIV epidemic under control in British Columbia. TasP¨ is a strategy many countries around the world have adopted.
New research from BC Centre for Excellence in HIV/AIDS (BC-CfE), Simon Fraser University (SFU) and Hawassa University in Ethiopia, found high rates HIV of drug resistance in Ethiopian children failing their first-line HIV treatment.
Indigenous, Latino, bisexual and single men less likely to be aware of newly publicly-funded HIV prevention medication (Vancouver, January 31, 2018) A new study shows most of gay, bi, men who have sex with men (MSM) and other MSM, are aware of PrEP (pre-exposure prophylaxis) – an HIV prevention drug recently made available at no
A study conducted by the BC Centre for Excellence in HIV/AIDS (BC-CfE) shows BC is on track to meet the UN 90-90-90 target, designed to accelerate efforts to end the AIDS epidemic. By 2020, 90% of people living with HIV in BC will be diagnosed, 91% of those on treatment and 90% on effective treatment and unable to pass on HIV (virologically suppressed).
Diabetes Canada adapting made-in-BC Treatment as Prevention¨ (TasP¨) strategy to diabetes, making 6 million Canadians aware of their status
BC Centre for Excellence in HIV/AIDS and Vancouver Coastal Health bring twenty teams together to improve access to suboxone and methadone and treatment
Study finds nearly 25% of women reported pregnancy after HIV diagnosis, 61% of the pregnancies were unplanned
The CIHR Gold Leaf Prize for Impact awarded to BC CfE lauds 25 years of leadership in the battle against HIV/AIDS
As the country’s premier national HIV research conference gets underway, the original co-signatories of the Canadian consensus statement on HIV and its transmission in the context of criminal law (2014) are releasing a statement expressing their deep concern about the ongoing, overly broad use of the criminal law in HIV non-disclosure cases, irrespective of the possibility of transmission or whether transmission actually occurred. Used correctly, an unbroken condom offers 100% protection against HIV transmission.
BC-CfE research finds HIV cases were averted through the implementation of Treatment as Prevention¨, needle distribution programs and opioid agonist therapy.
The largest bio-behavioural Canadian study of gay, bi and queer men (including trans men) has just launched from three major cities: Vancouver, Toronto and Montreal. The Engage Study will help create a clearer picture of the evolving epidemic among this at-risk group to inform more effective prevention programs.
Some of the province’s most vulnerable people will benefit from research into HIV/AIDS, addiction and viral hepatitis that will be carried out at the world-class Hope to Health Research Centre following a successful expansion project supported in part through $2 million in government funding. |
